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 Escherichia coli (E. coli) infections, colibacillosis, are responsible for significant economic 
losses in poultry industries. The increased resistance of E. coli strains to antibiotics has encouraged 
the search of new solutions to control severe infections ensuring good meat quality and minimising 
environmental impact. Bacteriophages (phages) have been pointed out as a valuable alternative to 
antibiotics in animal production. 
 Studies intending the development of an efficient, safe and competitive phage product to treat 
colibacillosis in commercial birds are presented. F78E was a phage isolated from poultry sewage and 
the lytic spectra showed that 35.14% of 148 avian pathogenic E.coli strains were sensitive to it. This 
phage exhibits strictly lytic characteristics as demonstrated through the prophage release induction 
test. TEM observations of this phage showed that it is a 16-19 phage, Myoviridae, roughly like T4, 
belonging to Caudovirales order. The RFLP pattern was defined with 3 restriction enzymes. Three 
different In vivo tests were performed according to FELASA principles of animal welfare, in order to 
evaluate the phage suspension toxicity, the phage dynamics in chicken’s organisms, and the phage 
efficiency. Phage toxicity was evaluated by injecting 1 ml of a phage crude lysate containing 1.67x108 
pfu/ml, intramuscularly in chickens.  The results revealed that this phage suspension did not promote 
any decrease in feed and water intake, or body weight lost during the in vivo trial and the post mortem 
necropsies did not show any macroscopic lesions in the internal organs. Phage dissemination in the 
chickens’ organs was assessed by administering intramuscularly, orally or by spray, different 
concentrations of the phage. The presence of F78E in the chicken’s lungs and air sacs was detected 
after 3, 10 and 24 hours of challenging with 1x108 pfu/ml by spray and orally, and 3 and 10 hours after 
administer 1x107 pfu/ml by the same way, suggesting that these two routes of administration are 
promising to treat respiratory E.coli infections. Therefore the in vivo efficacy of this phage was initially 
tested through the oral administration or by spray of 1ml of a phage concentration of 1x109 pfu/ml, just 
after injecting chickens intra-sacs, with 1.4x108 cfu of an avian pathogenic E. coli, F78E sensitive. A 
decrease of 25% of the chickens’ mortality and a reduction of 43% of morbidity was obtained.  
 The results of these studies suggest that the oral or spray administration of a suspension of 
phage F78E can safely and efficiently treat severe E. coli infections in poultry.  
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